Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Comperat

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
World Journal of Urology|November 13, 2010
Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre studyAlexandra Masson-Lecomte, Vincent Hupertan, Eva Comperat, et al.
BJU International|February 21, 2014
First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancerPierre Mozer, Morgan Rouprêt, Chloé Le Cossec, et al.
Ultrasound in Medicine & Biology|May 19, 2015
VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic TreatmentsThomas Payen, Alexandre Dizeux, Capucine Baldini, et al.
Urologic Oncology|July 22, 2011
Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective studyRaphaële Renard-Penna, Morgan Rouprêt, Eva Comperat, et al.
Plos One|January 8, 2020
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapiesAlexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, et al.
Ultrasound in Medicine & Biology|May 31, 2017
In Vivo Multiparametric Ultrasound Imaging of Structural and Functional Tumor Modifications during TherapyAlexandre Dizeux, Thomas Payen, Delphine Le Guillou-Buffello, et al.
Journal of Nephrology|April 26, 2021
More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimensJohannes Philipp Kläger, Ahmad Al-Taleb, Mladen Pavlovic, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Bladder cancer in neurological patients: analysis of a single-centre series]Jérôme Parra, Sarah Drouin, Eva Comperat, et al.
European Urology Oncology|January 5, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer PatientsOlivier Cussenot, Kirsten M Timms, Emmanuel Perrot, et al.
World Journal of Urology|April 28, 2022
Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institutionLouis Lenfant, Raphaele Renard-Penna, Yann de Rycke, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
World Journal of Urology|November 13, 2010
Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre studyAlexandra Masson-Lecomte, Vincent Hupertan, Eva Comperat, et al.
BJU International|February 21, 2014
First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancerPierre Mozer, Morgan Rouprêt, Chloé Le Cossec, et al.
Ultrasound in Medicine & Biology|May 19, 2015
VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic TreatmentsThomas Payen, Alexandre Dizeux, Capucine Baldini, et al.
Urologic Oncology|July 22, 2011
Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective studyRaphaële Renard-Penna, Morgan Rouprêt, Eva Comperat, et al.
Plos One|January 8, 2020
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapiesAlexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, et al.
Ultrasound in Medicine & Biology|May 31, 2017
In Vivo Multiparametric Ultrasound Imaging of Structural and Functional Tumor Modifications during TherapyAlexandre Dizeux, Thomas Payen, Delphine Le Guillou-Buffello, et al.
Journal of Nephrology|April 26, 2021
More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimensJohannes Philipp Kläger, Ahmad Al-Taleb, Mladen Pavlovic, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 15, 2008
[Bladder cancer in neurological patients: analysis of a single-centre series]Jérôme Parra, Sarah Drouin, Eva Comperat, et al.
European Urology Oncology|January 5, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer PatientsOlivier Cussenot, Kirsten M Timms, Emmanuel Perrot, et al.
World Journal of Urology|April 28, 2022
Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institutionLouis Lenfant, Raphaele Renard-Penna, Yann de Rycke, et al.
Pageof 16